JP2010529855A - 間葉系フィーダー細胞由来のパラ分泌シグナルならびにそれを用いる肝前駆体の増加および分化の調整 - Google Patents
間葉系フィーダー細胞由来のパラ分泌シグナルならびにそれを用いる肝前駆体の増加および分化の調整 Download PDFInfo
- Publication number
- JP2010529855A JP2010529855A JP2010512194A JP2010512194A JP2010529855A JP 2010529855 A JP2010529855 A JP 2010529855A JP 2010512194 A JP2010512194 A JP 2010512194A JP 2010512194 A JP2010512194 A JP 2010512194A JP 2010529855 A JP2010529855 A JP 2010529855A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- collagen
- layer
- liver
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004069 differentiation Effects 0.000 title claims abstract description 38
- 230000002440 hepatic effect Effects 0.000 title claims description 17
- 230000003076 paracrine Effects 0.000 title abstract description 6
- 210000004185 liver Anatomy 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 46
- 239000002243 precursor Substances 0.000 claims abstract description 42
- 238000000338 in vitro Methods 0.000 claims abstract description 27
- 230000035755 proliferation Effects 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims description 196
- 239000011159 matrix material Substances 0.000 claims description 65
- 210000003897 hepatic stem cell Anatomy 0.000 claims description 49
- 210000003999 epithelial cell of bile duct Anatomy 0.000 claims description 48
- 230000001605 fetal effect Effects 0.000 claims description 37
- 102000008186 Collagen Human genes 0.000 claims description 36
- 108010035532 Collagen Proteins 0.000 claims description 36
- 229920001436 collagen Polymers 0.000 claims description 36
- 102000007547 Laminin Human genes 0.000 claims description 28
- 108010085895 Laminin Proteins 0.000 claims description 28
- 108010067787 Proteoglycans Proteins 0.000 claims description 26
- 102000016611 Proteoglycans Human genes 0.000 claims description 25
- 210000003494 hepatocyte Anatomy 0.000 claims description 24
- 102000012422 Collagen Type I Human genes 0.000 claims description 22
- 108010022452 Collagen Type I Proteins 0.000 claims description 22
- 102000004266 Collagen Type IV Human genes 0.000 claims description 20
- 108010042086 Collagen Type IV Proteins 0.000 claims description 20
- 108010067306 Fibronectins Proteins 0.000 claims description 20
- 102000016359 Fibronectins Human genes 0.000 claims description 20
- 229920002674 hyaluronan Polymers 0.000 claims description 18
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 18
- 229940099552 hyaluronan Drugs 0.000 claims description 18
- 108010069502 Collagen Type III Proteins 0.000 claims description 17
- 102000001187 Collagen Type III Human genes 0.000 claims description 17
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 17
- 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 claims description 15
- 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 claims description 15
- 210000003566 hemangioblast Anatomy 0.000 claims description 14
- 229920002971 Heparan sulfate Polymers 0.000 claims description 11
- 230000001939 inductive effect Effects 0.000 claims description 11
- 239000012679 serum free medium Substances 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 7
- 102000001708 Protein Isoforms Human genes 0.000 claims description 6
- 108010029485 Protein Isoforms Proteins 0.000 claims description 6
- 210000002889 endothelial cell Anatomy 0.000 claims description 6
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- 210000003754 fetus Anatomy 0.000 claims description 2
- 210000000651 myofibroblast Anatomy 0.000 claims description 2
- 230000019635 sulfation Effects 0.000 claims description 2
- 238000005670 sulfation reaction Methods 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000004083 survival effect Effects 0.000 abstract description 10
- 210000002536 stromal cell Anatomy 0.000 description 46
- 102000004127 Cytokines Human genes 0.000 description 22
- 108090000695 Cytokines Proteins 0.000 description 22
- 238000003501 co-culture Methods 0.000 description 21
- 239000010410 layer Substances 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 16
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 15
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 14
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 14
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 14
- 210000000130 stem cell Anatomy 0.000 description 14
- 210000002744 extracellular matrix Anatomy 0.000 description 13
- 230000012010 growth Effects 0.000 description 13
- 230000005757 colony formation Effects 0.000 description 12
- 239000004033 plastic Substances 0.000 description 12
- 229920003023 plastic Polymers 0.000 description 12
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 11
- 239000003636 conditioned culture medium Substances 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 102000003815 Interleukin-11 Human genes 0.000 description 10
- 108090000177 Interleukin-11 Proteins 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 229940074383 interleukin-11 Drugs 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 102100036912 Desmin Human genes 0.000 description 8
- 108010044052 Desmin Proteins 0.000 description 8
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 8
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 8
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 108090000054 Syndecan-2 Proteins 0.000 description 8
- 210000000013 bile duct Anatomy 0.000 description 8
- 210000005045 desmin Anatomy 0.000 description 8
- 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 description 7
- 102000004889 Interleukin-6 Human genes 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108091016585 CD44 antigen Proteins 0.000 description 6
- 102000000013 Chemokine CCL3 Human genes 0.000 description 6
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 6
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000003364 immunohistochemistry Methods 0.000 description 6
- 210000004738 parenchymal cell Anatomy 0.000 description 6
- 210000000603 stem cell niche Anatomy 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 5
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 5
- 102000003816 Interleukin-13 Human genes 0.000 description 5
- 108090000176 Interleukin-13 Proteins 0.000 description 5
- 102000004058 Leukemia inhibitory factor Human genes 0.000 description 5
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 5
- 210000003038 endothelium Anatomy 0.000 description 5
- 229940100601 interleukin-6 Drugs 0.000 description 5
- 210000005229 liver cell Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000252203 Clupea harengus Species 0.000 description 4
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 4
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 4
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 4
- 102000004388 Interleukin-4 Human genes 0.000 description 4
- 108090000978 Interleukin-4 Proteins 0.000 description 4
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 4
- 241001529936 Murinae Species 0.000 description 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 4
- 210000000648 angioblast Anatomy 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 230000001143 conditioned effect Effects 0.000 description 4
- 230000003511 endothelial effect Effects 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 210000004024 hepatic stellate cell Anatomy 0.000 description 4
- 229940028885 interleukin-4 Drugs 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 102100027211 Albumin Human genes 0.000 description 3
- 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 3
- 101710155856 C-C motif chemokine 3 Proteins 0.000 description 3
- 108700012434 CCL3 Proteins 0.000 description 3
- 108050006947 CXC Chemokine Proteins 0.000 description 3
- 102000019388 CXC chemokine Human genes 0.000 description 3
- 102100023688 Eotaxin Human genes 0.000 description 3
- 101710139422 Eotaxin Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 3
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 3
- 102000003814 Interleukin-10 Human genes 0.000 description 3
- 108090000174 Interleukin-10 Proteins 0.000 description 3
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 3
- 108010002616 Interleukin-5 Proteins 0.000 description 3
- 102000000743 Interleukin-5 Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 230000008512 biological response Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000011325 microbead Substances 0.000 description 3
- 108010049224 perlecan Proteins 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- -1 αSMA + Proteins 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 239000012103 Alexa Fluor 488 Substances 0.000 description 2
- 239000012109 Alexa Fluor 568 Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102100032367 C-C motif chemokine 5 Human genes 0.000 description 2
- 108010055166 Chemokine CCL5 Proteins 0.000 description 2
- 102000016950 Chemokine CXCL1 Human genes 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 101800003838 Epidermal growth factor Proteins 0.000 description 2
- 102000010956 Glypican Human genes 0.000 description 2
- 108050001154 Glypican Proteins 0.000 description 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 2
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101150053185 P450 gene Proteins 0.000 description 2
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 102000019361 Syndecan Human genes 0.000 description 2
- 108050006774 Syndecan Proteins 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 229940116977 epidermal growth factor Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 208000006359 hepatoblastoma Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 108010060077 keratinocyte-derived chemokines Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 239000004017 serum-free culture medium Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 101150079978 AGRN gene Proteins 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 108700019743 Agrin Proteins 0.000 description 1
- 101001027327 Bos taurus Growth-regulated protein homolog alpha Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000001326 Chemokine CCL4 Human genes 0.000 description 1
- 108010055165 Chemokine CCL4 Proteins 0.000 description 1
- 108010014419 Chemokine CXCL1 Proteins 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101001039702 Escherichia coli (strain K12) Methyl-accepting chemotaxis protein I Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102100035716 Glycophorin-A Human genes 0.000 description 1
- 108091005250 Glycophorins Proteins 0.000 description 1
- 108050007237 Glypican-3 Proteins 0.000 description 1
- 108050009377 Glypican-5 Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000848653 Homo sapiens Tripartite motif-containing protein 26 Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102100032818 Integrin alpha-4 Human genes 0.000 description 1
- 108010041012 Integrin alpha4 Proteins 0.000 description 1
- 102100033011 Integrin beta-6 Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 1
- 108050001109 Interleukin-1 receptor type 1 Proteins 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 101150044441 PECAM1 gene Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102100035721 Syndecan-1 Human genes 0.000 description 1
- 108090000058 Syndecan-1 Proteins 0.000 description 1
- 102000003711 Syndecan-2 Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
- 108010006886 Vitrogen Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 102000046101 human AFP Human genes 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 108010021309 integrin beta6 Proteins 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 230000031142 liver development Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/80—Hyaluronan
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94443507P | 2007-06-15 | 2007-06-15 | |
| PCT/US2008/007397 WO2008156667A1 (en) | 2007-06-15 | 2008-06-13 | Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2010529855A true JP2010529855A (ja) | 2010-09-02 |
Family
ID=40136896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010512194A Pending JP2010529855A (ja) | 2007-06-15 | 2008-06-13 | 間葉系フィーダー細胞由来のパラ分泌シグナルならびにそれを用いる肝前駆体の増加および分化の調整 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20080318316A1 (https=) |
| EP (1) | EP2171040A4 (https=) |
| JP (1) | JP2010529855A (https=) |
| KR (1) | KR20100094970A (https=) |
| CN (1) | CN101868533A (https=) |
| AU (1) | AU2008266992A1 (https=) |
| BR (1) | BRPI0813353A2 (https=) |
| CA (1) | CA2727535A1 (https=) |
| IL (1) | IL202738A0 (https=) |
| IN (1) | IN2010KN00157A (https=) |
| MX (1) | MX2009013819A (https=) |
| TW (1) | TW200916581A (https=) |
| WO (1) | WO2008156667A1 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2016010082A1 (ja) * | 2014-07-16 | 2017-06-22 | 国立大学法人大阪大学 | ラミニンフラグメントの細胞培養基質活性増強方法 |
| JP2020505076A (ja) * | 2017-02-01 | 2020-02-20 | フェニックスソングス バイオロジカルズ，インコーポレイテッド | 肝細胞の共培養を含む組成物および方法 |
| WO2020075534A1 (ja) * | 2018-10-11 | 2020-04-16 | 一丸ファルコス株式会社 | 神経幹細胞増殖用培地 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070269412A1 (en) * | 2003-12-02 | 2007-11-22 | Celavie Biosciences, Llc | Pluripotent cells |
| US20100209399A1 (en) * | 2009-02-13 | 2010-08-19 | Celavie Biosciences, Llc | Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects |
| CN105456292B (zh) * | 2009-10-30 | 2019-03-26 | 北卡罗来纳大学教堂山分校 | 来自肝外胆管树的专能干细胞及其分离方法 |
| AU2011247984B2 (en) * | 2010-05-07 | 2015-04-30 | University Of North Carolina At Chapel Hill | Method of engrafting cells from solid tissues |
| ITMI20120896A1 (it) * | 2012-05-23 | 2013-11-24 | Bongulielmi Reto | Condroitina per uso in medicina |
| JP6435267B2 (ja) * | 2012-11-08 | 2018-12-05 | インジェネロン インコーポレイテッド | 再生細胞の培養、保存、及び投与のための培地 |
| US9533013B2 (en) | 2013-03-13 | 2017-01-03 | University Of North Carolina At Chapel Hill | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
| US11066649B2 (en) | 2014-03-19 | 2021-07-20 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for inducing human cholangiocyte differentiation |
| WO2016200340A1 (en) | 2015-06-12 | 2016-12-15 | Agency For Science, Technology And Research | Derivation of hepatic stem cells and mature liver cell types and uses thereof |
| US20170369849A1 (en) * | 2016-05-11 | 2017-12-28 | The University Of North Carolina At Chapel Hill | Compositions and methods for bioengineered tissues |
| EP3684386A4 (en) * | 2017-09-22 | 2021-06-30 | Lifenet Health | PLATE HEPATOCYTES AND THE PREPARATION AND USES OF THEM |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007059501A2 (en) * | 2005-11-16 | 2007-05-24 | University Of North Carolina At Chapel Hill | Extracellular matrix components for expansion or differentiation of hepatic progenitors |
| US20070134789A1 (en) * | 1991-08-07 | 2007-06-14 | Albert Einstein College Of Medicine Of Yeshiva University | Proliferation of hepatocyte precursors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6069005A (en) * | 1991-08-07 | 2000-05-30 | Albert Einstein College Of Medicine Of Yeshwa University | Hapatoblasts and method of isolating same |
| AU779706B2 (en) * | 1999-01-19 | 2005-02-10 | University Of North Carolina At Chapel Hill, The | Human liver progenitors |
| US7456017B2 (en) * | 1999-10-01 | 2008-11-25 | University Of North Carolina At Chapel Hill | Processes for clonal growth of hepatic progenitor cells |
| HUE032238T2 (en) * | 2002-03-15 | 2017-09-28 | Univ North Carolina Chapel Hill | Primitive and proximal liver stem cells |
| CA2689241A1 (en) * | 2006-06-28 | 2008-01-03 | Vesta Therapeutics, Inc. | Matrix and method for isolation of hepatic progenitor cells |
| WO2008109659A2 (en) * | 2007-03-06 | 2008-09-12 | University Of North Carolina At Chapel Hill | Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells |
-
2008
- 2008-06-13 CA CA2727535A patent/CA2727535A1/en not_active Abandoned
- 2008-06-13 EP EP08768437A patent/EP2171040A4/en not_active Withdrawn
- 2008-06-13 AU AU2008266992A patent/AU2008266992A1/en not_active Abandoned
- 2008-06-13 CN CN200880102251.3A patent/CN101868533A/zh active Pending
- 2008-06-13 JP JP2010512194A patent/JP2010529855A/ja active Pending
- 2008-06-13 MX MX2009013819A patent/MX2009013819A/es not_active Application Discontinuation
- 2008-06-13 KR KR1020107001049A patent/KR20100094970A/ko not_active Ceased
- 2008-06-13 TW TW097122138A patent/TW200916581A/zh unknown
- 2008-06-13 BR BRPI0813353-0A2A patent/BRPI0813353A2/pt not_active IP Right Cessation
- 2008-06-13 US US12/213,100 patent/US20080318316A1/en not_active Abandoned
- 2008-06-13 WO PCT/US2008/007397 patent/WO2008156667A1/en not_active Ceased
- 2008-06-13 IN IN157KON2010 patent/IN2010KN00157A/en unknown
-
2009
- 2009-12-15 IL IL202738A patent/IL202738A0/en unknown
-
2010
- 2010-09-10 US US12/923,253 patent/US8404483B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070134789A1 (en) * | 1991-08-07 | 2007-06-14 | Albert Einstein College Of Medicine Of Yeshiva University | Proliferation of hepatocyte precursors |
| WO2007059501A2 (en) * | 2005-11-16 | 2007-05-24 | University Of North Carolina At Chapel Hill | Extracellular matrix components for expansion or differentiation of hepatic progenitors |
Non-Patent Citations (1)
| Title |
|---|
| JPN5002024165; ＢＲＩＬＬ Ｓ: ＰＲＯＣＥＥＤＩＮＧＳ ＯＦ ＴＨＥ ＳＯＣＩＥＴＹ ＦＯＲ ＥＸＰＥＲＩＭＥＮＴＡＬ ＢＩＯＬＯＧＹ ＡＮＤ ＭＥＤＩＣＩＮＥ Ｖ２０４ Ｎ３, 19931201, Ｐ２６１-２６９ * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2016010082A1 (ja) * | 2014-07-16 | 2017-06-22 | 国立大学法人大阪大学 | ラミニンフラグメントの細胞培養基質活性増強方法 |
| JP2020505076A (ja) * | 2017-02-01 | 2020-02-20 | フェニックスソングス バイオロジカルズ，インコーポレイテッド | 肝細胞の共培養を含む組成物および方法 |
| WO2020075534A1 (ja) * | 2018-10-11 | 2020-04-16 | 一丸ファルコス株式会社 | 神経幹細胞増殖用培地 |
| JPWO2020075534A1 (ja) * | 2018-10-11 | 2021-09-02 | 一丸ファルコス株式会社 | 神経幹細胞増殖用培地 |
| JP7322053B2 (ja) | 2018-10-11 | 2023-08-07 | 一丸ファルコス株式会社 | 神経幹細胞増殖用培地 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009013819A (es) | 2010-05-17 |
| EP2171040A1 (en) | 2010-04-07 |
| US20080318316A1 (en) | 2008-12-25 |
| CN101868533A (zh) | 2010-10-20 |
| KR20100094970A (ko) | 2010-08-27 |
| TW200916581A (en) | 2009-04-16 |
| US8404483B2 (en) | 2013-03-26 |
| IL202738A0 (en) | 2011-08-01 |
| BRPI0813353A2 (pt) | 2014-10-14 |
| AU2008266992A1 (en) | 2008-12-24 |
| IN2010KN00157A (https=) | 2015-08-28 |
| WO2008156667A1 (en) | 2008-12-24 |
| EP2171040A4 (en) | 2010-08-04 |
| US20110065188A1 (en) | 2011-03-17 |
| CA2727535A1 (en) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529855A (ja) | 間葉系フィーダー細胞由来のパラ分泌シグナルならびにそれを用いる肝前駆体の増加および分化の調整 | |
| JP7372910B2 (ja) | ヒト多能性幹細胞由来の胸腺オルガノイドのインビトロ生成 | |
| Zhang et al. | Co-culture of umbilical cord blood CD34þ cells with human mesenchymal stem cells | |
| Pournasr et al. | In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells | |
| US10358629B2 (en) | Regulating stem cells | |
| JP4085062B2 (ja) | 霊長類の胚性幹細胞から由来した内皮細胞 | |
| US9605244B2 (en) | Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells | |
| Hall et al. | Phenotypic differentiation of TGF-β1-responsive pluripotent premesenchymal prehematopoietic progenitor (P4 stem) cells from murine bone marrow | |
| Kim et al. | Sphere formation of adipose stem cell engineered by poly-2-hydroxyethyl methacrylate induces in vitro angiogenesis through fibroblast growth factor 2 | |
| Pan et al. | Biomimetic macroporous pcl scaffolds for ex vivo expansion of cord blood‐derived CD34+ cells with feeder cells support | |
| US20220249613A1 (en) | Cell culture for treating disease in the lower limbs | |
| Kinebuchi et al. | Direct induction of layered tissues from mouse embryonic stem cells: potential for differentiation into urinary tract tissue | |
| HK1149942A (en) | Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same | |
| Wencel et al. | Dried human skin fibroblasts as a new substratum for functional culture of hepatic cells | |
| Mathews et al. | Standardizing transdifferentiation of rabbit bone marrow mesenchymal stem cells to corneal lineage by simulating corneo-limbal cues. J | |
| Stegge | Interactions between hematopoietic stem cells and their niche | |
| US20200291350A1 (en) | Hepatocyte construct and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110607 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130819 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130826 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130924 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131001 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131024 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131031 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140225 |